Our findings, based on cell lines, patient samples, and AML mouse models, suggest that LSD1 inhibition on its own de-represses pro-myeloid differentiation expression programs but fails to downregulate drivers of stemness and proliferation. This evidence concerns the gene KDM1A and acute myeloid leukemia.